Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/2012
03/21/2012CN102388054A Thiazolopyridine sirtuin modulating compounds
03/21/2012CN102388039A Pyrazole derivatives used as CCR4 receptor antagonists
03/21/2012CN102388032A Substituted piperidines as CCR3 antagonists
03/21/2012CN102387808A Immunopotentiating composition and process for producing same
03/21/2012CN102382192A Hypoallergenic recombinant immunotoxin, and preparation method and application thereof
03/21/2012CN102382154A Saponin compound, preparation method for same, and application thereof in immunologic adjuvant preparation
03/21/2012CN102382113A Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith
03/21/2012CN102382102A Amide compound
03/21/2012CN102382088A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
03/21/2012CN102382075A Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
03/21/2012CN102382014A Aminopeptidase N inhibitor, preparation method and application
03/21/2012CN102380101A Pholcodine-containing compound pharmaceutical preparation for treating cold
03/21/2012CN102380090A G-CSF (granulocyte-colony stimulating factor) dimmer applied to treat neutropenia
03/21/2012CN102380088A Prescription and preparation method of thymopeptide-5 injection
03/21/2012CN102379962A Traditional Chinese medicine combination for healthcare and treatment of livestock
03/21/2012CN102379931A Novel application of Chinese medicinal composition
03/21/2012CN102379919A Epidemic prevention pellet
03/21/2012CN102379908A Wall breaking method for fresh and live ganoderma lucidum spores
03/21/2012CN102379904A Proteoglycan protein tablet and preparation method thereof
03/21/2012CN102379874A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
03/21/2012CN102379852A Freeze-dried mugwort leaf polysaccharide powder injection for injection and its preparation method and application
03/21/2012CN102379838A Method for preparing relaxing and face-cleansing cosmetics and application
03/21/2012CN102100690B Application of flavonoids compounds in preparation of anticomplement medicaments
03/21/2012CN101979084B Chinese medicinal composition for warming kidney and tonifying yang and preparation method thereof
03/21/2012CN101874850B Medicament for treating chronic urticaria
03/21/2012CN101745023B Compound bee product and preparation method thereof
03/21/2012CN101724541B Chinese traditional medicine health-care wine for enhancing immunity and relieving physical fatigue and preparation method thereof
03/21/2012CN101721706B Medicine composition containing matrine class alkaloid, preparation method and pharmaceutical application
03/21/2012CN101721565B Health care bee product and preparation method thereof
03/21/2012CN101721538B Health-care cigarette prepared from rhiizoma dioscoreae from Henan of China and chrysanthemum and used for reinforcing immunological function
03/21/2012CN101711826B Traditional Chinese medicine composite for improving poulard productivity and application thereof
03/21/2012CN101711786B Preparation used for relieving osteoarthropathy and enhancing immunity
03/21/2012CN101580553B Preparation method of cynomorium songaricum polysaccharide
03/21/2012CN101553216B Treatment of inflammatory diseases
03/21/2012CN101496887B Medicament for treating acute hot, itching and wet severe type and chronic urticaria
03/21/2012CN101496814B Application of mesenchymal stem cell in preparing medicament for inhibiting chronic rejection after blood vessel transplantation
03/21/2012CN101164543B Acyl pseudopeptides bearing a functionalised auxiliary spacer
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138335 Carboxylic acid compounds and medicinal compositions containing the same as the active ingredient
03/20/2012US8138323 Cytokines; side effect reduction; bactericides; antitumor agents; anticarcinogenic agents
03/20/2012US8138314 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations
03/20/2012US8138311 Modified proteins, designer toxins, and methods of making thereof
03/20/2012US8138195 Inhibitors of human phosphatidylinositol 3-kinase delta
03/20/2012US8138172 8-oxoadenine derivatives acting as modulators of TLR7
03/20/2012US8138170 Inhibiting transplant rejection and inflammatory cell accumulation; wound healing agents, antiallergens
03/20/2012US8138141 HMG1 antibody for treating inflammatory conditions
03/20/2012US8137969 Neural progenitor cells derived from embryonic stem cells
03/20/2012US8137915 Genes involved in intestinal inflammatory diseases and use thereof
03/20/2012CA2524441C Treatment of lupus targeting the macrophages or the folate receptor
03/20/2012CA2489526C Stabilized formulations of alpha adrenergic receptor antagonists and uses thereof
03/20/2012CA2446981C Method for obtaining antigen-specific tr1 regulatory lymphocytes
03/20/2012CA2446872C Immune-modulating peptide
03/20/2012CA2429172C Novel mutant allergens
03/20/2012CA2410901C Methods and compounds for controlled release of recombinant parvovirus vectors
03/20/2012CA2402719C Method of preparing alkylated salicylamides via a dicarboxylate intermediate
03/20/2012CA2363067C Compounds and methods to inhibit or augment an inflammatory response
03/20/2012CA2351580C Stabilization of macrolides
03/20/2012CA2299560C Human defensin def-x, gene and dnac, composition containing same and diagnostic and therapeutic applications
03/20/2012CA2296842C Ligands, including antibodies, showing reactivity against endocrine cells
03/20/2012CA2224320C Method of promoting hypoallergenicity or tolerogenic immune response and compositions therefor
03/17/2012CA2752396A1 Pertussis antibodies and uses thereof
03/15/2012WO2012034091A1 Imidazo [1, 2] pyridazin compounds and compositions as trk inhibitors
03/15/2012WO2012034079A2 Macrolide dosage forms
03/15/2012WO2012033348A2 Composition for the prevention or treatment of allergic diseases comprising 2-linoleoyl glycerol
03/15/2012WO2012033195A1 Heterocyclic compound
03/15/2012WO2012033069A1 Prostaglandin d synthase inhibitory piperidine compounds
03/15/2012WO2012031466A1 2-(p-octylphenylethyl)-2-amino propanediol derivatives and uses thereof
03/15/2012WO2012003477A3 Inhibition of inflammation bysimultaneous blockade of multiple prostanoid receptors
03/15/2012WO2011098569A9 Process for producing an allergen extract
03/15/2012US20120065385 Dendritic cell co-stimulatory molecules
03/15/2012US20120065374 Dendritic cell co-stimulatory molecules
03/15/2012US20120065271 Method of accelerating muscle growth, decreasing fat deposits and improving feed efficiency in livestock animals
03/15/2012US20120065270 Potassium ion channel modulators and uses thereof
03/15/2012US20120065202 PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
03/15/2012US20120065192 N-aryl-2-(2-arylaminopyrimidin-4-yl)pyrrol-4-carboxamide derivatives as mps1 kinase inhibitors
03/15/2012US20120065187 Heterocyclic inhibitors of histamine receptors for the treatment of disease
03/15/2012US20120065183 Tetrahydro-Pyrido-Pyrimidine Derivatives
03/15/2012US20120065174 Compositions of glycopyrronium salt for inhalation
03/15/2012US20120065173 Chemical compounds
03/15/2012US20120065167 Domperidone at a low daily dose for use in the treatment or prevention of a disease associated with an alteration of the immune response
03/15/2012US20120065153 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof
03/15/2012US20120065151 Substances Mixture, Use and Infusion Solution
03/15/2012US20120065134 Cd40-l inhibitory phylomer peptides
03/15/2012US20120065125 Methods and compositions for the treatment of cancer or other diseases
03/15/2012US20120064625 Nucleic Acids, Polypeptides, Compositions, and Methods for Modulating Apoptosis
03/15/2012US20120064600 Anti-5t4 antibodies and uses thereof
03/15/2012US20120064571 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
03/15/2012US20120064177 Method of preparing an intranasal composition and intranasal compositions obtainable thereby
03/15/2012US20120064169 Multiple antigen delivery system using hepatitis e virus-like particle
03/15/2012US20120064155 Oral pharmaceutical composition for use in respiratory diseases
03/15/2012US20120064151 Enhanced immune response in avian species
03/15/2012US20120064144 Method of treating eczema
03/15/2012US20120064127 Composition for improving membrane composition and functioning of cells
03/15/2012US20120064124 Macrolide dosage forms
03/15/2012US20120064122 Treatment of autoimmune inflammation using mir-155
03/15/2012US20120064121 Pyridine compounds for inflammation and immune-related uses
03/15/2012US20120064120 Neisserial vaccine compositions comprising a combination of antigens
03/15/2012US20120064119 Neisserial vaccine compositions comprising a combination of antigens
03/15/2012US20120064118 Bacteria strains having a high anti-inflammatory activity
03/15/2012US20120064117 Tetravalent influenza vaccine and use thereof